about
Liver transplantation for severe Amanita phalloides mushroom poisoningSolid-organ transplantation in older adults: current status and future researchOPTN/SRTR 2013 Annual Data Report: liver.OPTN/SRTR 2015 Annual Data Report: Liver.Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients.Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study.Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States.Rat hepatocytes exhibit basolateral Na+/HCO3- cotransportLiver transplantation for erythropoietic protoporphyria liver disease.Hepatitis B immune globulin for life versus limited use: I favor limited duration of therapy.The role of immunosuppression in recurrence of hepatitis C.Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2Frequency and prognosis of acute pancreatitis associated with acute hepatitis E: A systematic review.Role of tacrolimus in the evolution of liver transplantation.Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure.Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients.The impact of MELD allocation on simultaneous liver-kidney transplantation.Azathioprine hepatotoxicity after liver transplantation.Simultaneous liver-kidney transplantation summit: current state and future directions.Immunosuppression in HCV-positive liver-transplant recipients.Making the case for the development of a vaccination against hepatitis E virus.Clinical frontiers in liver transplantation.The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.Case studies of the hepatitis B patient: a panel discussion.Hepatitis C and B in liver transplantation.Changing indications for liver transplantation.Treatment of hepatic failure--1996: current concepts and progress toward liver dialysis.Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.Should liver transplantation be performed for patients with chronic hepatitis B? Yes!Long-term management of biliary tract complications.Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group.Methods to estimate and analyze medical care resource use. An example from liver transplantation.Acidic vesicles in cultured rat hepatocytes. Identification and characterization of their relationship to lysosomes and other storage vesicles.Na+-H+ exchange activity in rat hepatocytes: role in regulation of intracellular pH.Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation.Antibody to the host cellular gene-derived epitope GOR-1 in liver transplant recipients with hepatitis C virus infection.Hepatitis C in liver transplant recipients.
P50
Q28283913-A280A8E8-AC07-4EF7-AE79-F06B73D98320Q28727427-72EB9637-4109-4B10-A92F-C8C27630BE94Q30886222-888BCFC2-33EE-48B6-810A-2A5BB17AE8DAQ31152687-045625E8-7D5B-493C-B4C4-692DEED5876EQ33328295-0564E515-9B93-4CDF-B203-9F22F4972153Q33416624-9DB3E9CC-0923-47B4-B567-A7689ED963C6Q34074790-7C6CB6A3-1C1A-4B14-8CEA-384ED5A97696Q34206050-D0873762-52CE-4982-8E71-D763DF87CA54Q34447717-2E39A4A8-E3B3-401F-B209-45719CEE0705Q34562963-ECE44DE6-F064-4D6B-BB01-2A62855B0A60Q34936305-59997836-96B8-49DD-90B0-55255A8F2B2CQ35572068-61A35AC5-7DA7-42CC-9D97-318C55151DE6Q35610980-CD38DEBC-D6AE-4E14-935D-BE266211D0D6Q35655323-F376EF05-EA56-40F7-BB1A-EA75F79B6BCEQ35808063-1BC447EB-FC0F-4597-8CA7-6033DACC1CE2Q35988322-14AE3C21-F7AA-4D82-BB0D-A0D18772EA1FQ36547798-DF3B8875-3F31-4293-9324-021B2B729FADQ37376435-BE1D1BB4-8DBA-4FE4-8A29-D66898ED3F53Q37448534-95EE9A48-281D-493A-BFAE-38643B7BF3D8Q38028515-D0BB7C27-3E56-4F27-8C8D-F355D3906C7BQ38057955-00EA2780-1135-4658-9D91-A53DB0059F38Q38212391-6345AB68-876A-4084-9AC0-180CD1A2FD4EQ39106339-D982D018-68E3-418E-8277-34469DF3480DQ40581424-DB559040-2FEE-4286-837C-3F3721DECDF1Q40636558-2DE8F9E8-8D01-440D-BB17-FB96DD6177A1Q40757220-D866B3FD-4481-4E7A-8B9F-8E26EB9E94C2Q40895146-F84DA7CC-F9B0-4F82-B00F-3BC19527B0C9Q40915622-C40F2A5C-8723-4DF1-9870-E378091123BEQ40986109-DD5CC8B0-C29B-4F13-8743-403B2C6A8906Q41481045-ED5A9B90-05F0-4EC2-9C52-F53351BFD887Q41622995-6D74B5C2-A28B-4891-BAA3-FBE0C28972A9Q41623072-A8E01B32-82F0-42DA-8334-D0DEBA5DE7BDQ41648002-802359FE-12C9-46A8-9377-A8D69F02DDF4Q41693562-AFE95686-B238-4F9D-9161-0BBCF2223E1CQ41913796-28BABB0C-0EDA-4D05-929B-1541A17E112CQ42492574-351CF767-CC99-4859-A462-F757ED5AEC27Q42603832-64574247-BD06-4476-8453-C3229FC92320Q42980498-FD6595EB-C164-4BD3-9CAF-0BBD2823238CQ42981541-09D0ABE5-1F1B-4B42-83F9-4961CAD86633Q42986453-109F395F-01B1-4F74-88FA-D3723E5F9ACB
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
John Lake
@ast
John Lake
@en
John Lake
@es
John Lake
@nl
type
label
John Lake
@ast
John Lake
@en
John Lake
@es
John Lake
@nl
prefLabel
John Lake
@ast
John Lake
@en
John Lake
@es
John Lake
@nl
P1006
P214
P1006
P1153
13310136500
P214
P31
P496
0000-0002-4332-0528
P735
P7859
lccn-nb99141903